Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Reversible posterior leukoencephalopathy syndrome associated with oxaliplatin.

Literature DB >> 18024878

Reversible posterior leukoencephalopathy syndrome associated with oxaliplatin.

Daryl M Pinedo¹, Farheen Shah-Khan, Prabodh C Shah.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2007 PMID： 18024878 DOI： 10.1200/JCO.2007.13.5954

Source DB: PubMed Journal: J Clin Oncol ISSN： 0732-183X Impact factor: 44.544

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

1. Gemcitabine and cisplatin chemotherapy induced reversible posterior leukoencephalopathy syndrome in a bladder cancer patient.

Authors: Takahiro Maeda; Eiji Kikuchi; Kazuhiro Matsumoto; Satoshi Yazawa; Jun Hagiuda; Akira Miyajima; Ken Nakagawa; Hirokazu Fujiwara; Haruhiko Hoshino; Mototsugu Oya
Journal: Int J Clin Oncol Date: 2010-03-30 Impact factor: 3.402

2. Reversible posterior leukoencephalopathy syndrome associated with concurrent bevacizumab, gemcitabine, and oxaliplatin for cholangiocarcinoma.

Authors: Yongen Chang; Gilbert Mbeo; Susan J Littman
Journal: J Gastrointest Cancer Date: 2012-09

Review 3. Posterior reversible encephalopathy syndrome induced by anti-VEGF agents.

Authors: Camille Tlemsani; Olivier Mir; Pascaline Boudou-Rouquette; Olivier Huillard; Karin Maley; Stanislas Ropert; Romain Coriat; François Goldwasser
Journal: Target Oncol Date: 2011-11-17 Impact factor: 4.493

4. Lysergic acid amide-induced posterior reversible encephalopathy syndrome with status epilepticus.

Authors: Stephane Legriel; Fabrice Bruneel; Odile Spreux-Varoquaux; Aurelie Birenbaum; Marie Laure Chadenat; François Mignon; Nathalie Abbosh; Matthieu Henry-Lagarrigue; Laure Revault D'Allonnes; Pierre Guezennec; Gilles Troche; Jean Pierre Bedos
Journal: Neurocrit Care Date: 2008 Impact factor: 3.210

Reversible posterior leukoencephalopathy syndrome associated with oxaliplatin.

1. Gemcitabine and cisplatin chemotherapy induced reversible posterior leukoencephalopathy syndrome in a bladder cancer patient.

2. Reversible posterior leukoencephalopathy syndrome associated with concurrent bevacizumab, gemcitabine, and oxaliplatin for cholangiocarcinoma.

Review 3. Posterior reversible encephalopathy syndrome induced by anti-VEGF agents.

4. Lysergic acid amide-induced posterior reversible encephalopathy syndrome with status epilepticus.

Review 5. Posterior reversible encephalopathy syndrome: a neurologic phenomenon in cancer patients.

6. Oxaliplatin-induced posterior reversible encephalopathy syndrome (PRES).

7. Atypical reversible leucoencephalopathy syndrome after bevacizumab/folfox regimen for metastatic colon cancer.

8. Oxaliplatin-Induced Tonic-Clonic Seizures.

9. Atypical presentation of posterior reversible encephalopathy syndrome: Two cases.

10. Disturbance of consciousness due to hyperammonemia and lactic acidosis during mFOLFOX6 regimen: Case report.